Pharmacokinetic Drug-drug Interaction Study of Dovitinib (TKI258) in Patients With Advanced Solid Tumors
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Advanced Solid Tumors, Excluding Breast Cancer
Interventions: DRUG: caffeine|DRUG: diclofenac|DRUG: omeprazole|DRUG: midazolam|DRUG: TKI258
Sponsor: Novartis Pharmaceuticals